Lisa Gill
Stock Analyst at JP Morgan
(3.25)
# 1,089
Out of 5,138 analysts
131
Total ratings
50%
Success rate
2.46%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Overweight | $50 | $43.03 | +16.20% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $80.56 | +25.37% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $23.02 | -0.09% | 6 | Dec 17, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $23.85 | +38.36% | 6 | Nov 13, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $6 → $5 | $2.66 | +87.97% | 2 | Nov 11, 2025 | |
| PGNY Progyny | Maintains: Neutral | $25 → $26 | $24.68 | +5.35% | 1 | Nov 11, 2025 | |
| COR Cencora | Maintains: Overweight | $344 → $417 | $354.45 | +17.65% | 3 | Nov 11, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $291 → $317 | $267.10 | +18.68% | 2 | Nov 7, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $428 → $375 | $274.87 | +36.43% | 14 | Nov 4, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $384 → $394 | $381.00 | +3.41% | 6 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $310 → $425 | $337.48 | +25.93% | 10 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $821 → $853 | $839.67 | +1.59% | 14 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $9.48 | +5.49% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $190.16 | -0.08% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $21.02 | +42.72% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $36.11 | +13.54% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $284.44 | -10.00% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $213.63 | -32.13% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $38.59 | -53.36% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $5.81 | -13.87% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $15.84 | +76.77% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $6.58 | +36.88% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $8.88 | +102.70% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $193.20 | +104.45% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $202.96 | -8.36% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $201.87 | -30.65% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $486.66 | -31.78% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.98 | +822.51% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.41 | +7.96% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $77.66 | +6.88% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $47.20 | +107.63% | 1 | Jan 6, 2023 |
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $43.03
Upside: +16.20%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $80.56
Upside: +25.37%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $23.02
Upside: -0.09%
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $23.85
Upside: +38.36%
GoodRx Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.66
Upside: +87.97%
Progyny
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $24.68
Upside: +5.35%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $344 → $417
Current: $354.45
Upside: +17.65%
Labcorp Holdings
Nov 7, 2025
Maintains: Overweight
Price Target: $291 → $317
Current: $267.10
Upside: +18.68%
The Cigna Group
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $274.87
Upside: +36.43%
Elevance Health
Oct 28, 2025
Maintains: Overweight
Price Target: $384 → $394
Current: $381.00
Upside: +3.41%
Oct 9, 2025
Maintains: Overweight
Price Target: $310 → $425
Current: $337.48
Upside: +25.93%
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $839.67
Upside: +1.59%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $9.48
Upside: +5.49%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $190.16
Upside: -0.08%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $21.02
Upside: +42.72%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $36.11
Upside: +13.54%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $284.44
Upside: -10.00%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $213.63
Upside: -32.13%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $38.59
Upside: -53.36%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $5.81
Upside: -13.87%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $15.84
Upside: +76.77%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $6.58
Upside: +36.88%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $8.88
Upside: +102.70%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $193.20
Upside: +104.45%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $202.96
Upside: -8.36%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $201.87
Upside: -30.65%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $486.66
Upside: -31.78%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.98
Upside: +822.51%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.41
Upside: +7.96%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $77.66
Upside: +6.88%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $47.20
Upside: +107.63%